Bertrand J. Jean‐Claude

Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes

Hizbullah Khan, Amin Badshah, G. Murtaz et al. · European Journal of Medicinal Chemistry · 2011 · 97 citations · Full text

Natural Sciences, Chemistry, Oncology +14

Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells

Jun Tian, Fatmah Al Raffa, Meiou Dai et al. · British Journal of Cancer · 2018 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17

The Combi-Targeting Concept:  Synthesis of Stable Nitrosoureas Designed to Inhibit the Epidermal Growth Factor Receptor (EGFR)

Juozas Domarkas, Fabienne Dudouit, Christopher Williams et al. · Journal of Medicinal Chemistry · 2006 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Design of a Chimeric 3-Methyl-1,2,3-triazene with Mixed Receptor Tyrosine Kinase and DNA Damaging Properties: A Novel Tumor Targeting Strategy

Stephanie L. Matheson, James P. McNamee, Bertrand J. Jean‐Claude · Journal of Pharmacology and Experimental Therapeutics · 2001 · 60 citations

Medicine, Oncology, Pharmacology +15

Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide

Zeinab Sharifi, Bassam Abdulkarim, Brian Meehan et al. · Clinical Cancer Research · 2019 · 57 citations

Medicine, Molecular Biology, Oncology +17